Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Jun;2(6):557-65.
doi: 10.1158/1940-6207.CAPR-08-0188. Epub 2009 May 26.

The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model

Affiliations
Comparative Study

The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model

John C Mavropoulos et al. Cancer Prev Res (Phila). 2009 Jun.

Abstract

Purpose: Numerous dietary factors elevate serum levels of insulin and insulin-like growth factor I (IGF-I), both potent prostate cancer mitogens. We tested whether varying dietary carbohydrate and fat, without energy restriction relative to comparison diets, would slow tumor growth and reduce serum insulin, IGF-I, and other molecular mediators of prostate cancer in a xenograft model.

Experimental design: Individually caged male severe combined immunodeficient mice (n = 130) were randomly assigned to one of three diets (described as percent total calories): very high-fat/no-carbohydrate ketogenic diet (NCKD: 83% fat, 0% carbohydrate, 17% protein), low-fat/high-carbohydrate diet (LFD: 12% fat, 71% carbohydrate, 17% protein), or high-fat/moderate-carbohydrate diet (MCD: 40% fat, 43% carbohydrate, 17% protein). Mice were fed to maintain similar average body weights among groups. Following a preliminary feeding period, mice were injected with 1 x 10(6) LNCaP cells (day 0) and sacrificed when tumors were >or=1,000 mm(3).

Results: Two days before tumor injection, median NCKD body weight was 2.4 g (10%) and 2.1 g (8%) greater than the LFD and MCD groups, respectively (P < 0.0001). Diet was significantly associated with overall survival (log-rank P = 0.004). Relative to MCD, survival was significantly prolonged for the LFD (hazard ratio, 0.49; 95% confidence interval, 0.29-0.79; P = 0.004) and NCKD groups (hazard ratio, 0.59; 95% confidence interval, 0.37-0.93; P = 0.02). Median serum insulin, IGF-I, IGF-I/IGF binding protein-1 ratio, and IGF-I/IGF binding protein-3 ratio were significantly reduced in NCKD relative to MCD mice. Phospho-AKT/total AKT ratio and pathways associated with antiapoptosis, inflammation, insulin resistance, and obesity were also significantly reduced in NCKD relative to MCD tumors.

Conclusions: These results support further preclinical exploration of carbohydrate restriction in prostate cancer and possibly warrant pilot or feasibility testing in humans.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Figures

Fig. 1
Fig. 1
Mouse energy intake and body weights. One hundred thirty 8-wk-old male SCID mice were fed a LFD, MCD, or NCKD for 42 d and then injected s.c. in the flank with 1 × 106 LNCaP tumor cells in 0.1 mL of Matrigel. Mice were weighed twice per week from the start of the experiment. Values are expressed as the median of each group. A, energy intake was measured for each mouse thrice per week by subtracting the weight of uneaten food from the weight of the food placed into the feeding receptacles at the start of each feeding period. B, mice were weighed twice per week from the start of the experiment. Values are expressed as the median of each group.
Fig. 2
Fig. 2
A, LNCaP xenograft tumor growth in SCID mice. Mice were injected s.c. on day 0 in the flank with 1 × 106 LNCaP tumor cells in 0.1 mL of Matrigel. Once the tumors became palpable, tumor volume was measured twice per week. Values are expressed as the median of each group. Curves only extend up to the point at which ≥50% of the mice in the respective group had been sacrificed, and therefore median tumor volume is not meaningful. B, Kaplan-Meier survival plot of overall mouse survival by diet group on days 45 and 92.
Fig. 3
Fig. 3
Box-plot expression of fasting serum hormone concentrations at the time of sacrifice across all dietary groups. A, insulin; B, IGF-I; C, IGFBP-3; D, ratio of IGF-I/IGFBP-3. Upper and lower box borders represent 25th and 75th percentile values, respectively. Horizontal line within the box represents the median value. Upper and lower whiskers correspond to 95th and 5th percentile values, respectively.
Fig. 4
Fig. 4
Box-plot expression of fasting serum hormone concentrations at the time of sacrifice across all dietary groups. A, IGFBP-1; B, ratio of IGF-I/IGFBP-1; C, IGFBP-2. Upper and lower box borders represent 25th and 75th percentile values, respectively. Horizontal line within the box represents the median value. Upper and lower whiskers correspond to 95th and 5th percentile values, respectively.
Fig. 5
Fig. 5
Western blot analysis of p-AKT, t-AKT, and β-actin in pooled tumor lysates for each diet group (n = 5 per group). Total AKT levels reflect phosphorylated and unphosphorylated forms, whereas p-AKT reflects levels of the Ser473 phosphoform. β-Actin was used as an internal control for protein loading and transfer.

References

    1. McKeehan WL, Adams PS, Rosser MP. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res. 1984;44:1998–2010. - PubMed
    1. Iwamura M, Sluss PM, Casamento JB, Cockett AT. Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate. 1993;22:243–52. - PubMed
    1. Hsing AW, Chua S, Jr, Gao YT, et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst. 2001;93:783–9. - PubMed
    1. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma IGF-1 and prostate cancer risk: a prospective study. Science. 1998;279:563–6. - PubMed
    1. Freedland SJ, Mavropoulos JC, Wang A, et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68:11–9. - PMC - PubMed

Publication types

MeSH terms